MINK MidwestMD
Membership Organizations · Kansas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1500 SW 10th Ave, Topeka, Kansas, 66604,...Phone Number
(785) 354-5880Website
www.mink-midwest.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About MINK MidwestMD
CSRA is an organization dedicated to promoting physician and provider recruitment and retention in the Central and Midwest United States. They offer a platform for job seekers to explore and apply for various physician job opportunities while providing resources and networking opportunities for recruiters. As an affiliate of the Association for Advancing Physician and Provider Recruitment (AAPPR), CSRA connects recruitment leaders to enhance their careers. Their services include educational resources, annual conferences, and professional networking events.Explore more
MINK MidwestMD Org Chart
MB
Service Director, Client
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MINK MidwestMD your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if MINK MidwestMD had a recent Job posting/layoffs
Product Launch: Get notified when MINK MidwestMD launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at MINK MidwestMD
Check if MINK MidwestMD has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once MINK MidwestMD has new funding data
Check out if MINK MidwestMD is spiking on competitors!
MINK MidwestMD, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on MINK MidwestMD recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined MINK MidwestMD as Masked Content
Find more new buyers
Compare Similar Companies to MINK MidwestMD
Compare insights from companies similar to MINK MidwestMD, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MINK MidwestMD is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
MINK MidwestMD is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about MINK MidwestMD.
MINK MidwestMD Tech Stack
A closer look at the technologies used by MINK MidwestMD
MINK MidwestMD News & Media
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
NEW YORK, May 25, 2022 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, announced that its virtual-only Annual Meeting of Shareholders will be held at 5:00 PM ET on June 8, 2022.MiNK Therapeutics Corporate Update and First Quarter 2022 Financial Report
NEW YORK, May 10, 2022 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today reported financial results for the first quarter 2022 and provided a corporate business update.MiNK Therapeutics to Report First Quarter 2022 Financial Results and Business Update
NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, announced it will release its first quarter 2022 financial results and business update before the market opens on Tuesday, May 10, 2022. The financial report and an update on business progress wiMiNK Therapeutics to Report Fourth Quarter & Full Year 2021 Financial Results and Business Update
NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, announced it will release its independent fourth quarter and full year 2021 financial results and a business update before the market opens on Friday, March 18, 2022.
Read more news
Top Membership Organizations Companies
See more top companies
Frequently Asked Questions Regarding MINK MidwestMD
Sign Up For FreeTo access detailed company insights
CSRA is an organization dedicated to promoting physician and provider recruitment and retention in the Central and Midwest United States. They offer a platform for job seekers to explore and apply for various physician job opportunities while providing resources and networking opportunities for recruiters. As an affiliate of the Association for Adv... Read More
